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Abstract
The neuroanatomical substrate of seizures induced by picomolar amounts of corticotropin-
releasing hormone in infant rats was investigated. Electrographic and behavioral phenomena were
monitored in 42 rat pups aged 5 to 22 days. Rat pups carried bipolar electrodes implanted in
subcortical limbic structures, as well as cortical electrodes and intracerebroventricular cannulae.
The administration of corticotropin-releasing hormone produced age-specific seizures within
minutes, which correlated with rhythmic amygdala discharges. Paroxysmal hippocampal and
cortical discharges developed subsequently in some rats. Corticotropin-releasing hormone-induced
electrographic and behavioral seizures originate in the amygdala.
Corticotropin-releasing hormone (CRH) is a 41-amino acid neuropeptide, isolated originally
from the mammalian hypothalamus [1], It has since been shown to be distributed
nonrandomly in the central nervous system, and to perform roles other than the control of
secretion of ACTH and endorphins from the anterior pituitary [2]. Specifically, central
transduction of stress, anxiety, depression, and anorexia have been demonstrated [2, 3].
CRH activates neurons both in vivo and in vitro [4–9]. The peptide increases both
spontaneous and evoked spike discharge from locus ceruleus neurons in vivo [4], CRH
induces neuronal depolarization in CA1 and CA3 hippocampal pyramidal cells in the slice
preparation in vitro [5]. CRH administered into the cerebral ventricles of adult rats causes
epileptiform discharges in the amygdala after a 1- to 3-hour delay, which spread to the
dorsal hippocampus [6]. These discharges progress over 3 to 7 hours to behavioral and
electrographic seizures. The doses needed for frank seizure generation in adult rats axe 1–5
to 3–75 × 10−9 mol (0.75–1.88 × 10−9 mol/gm of brain weight) [6–8].
We have previously shown that CRH is a far more rapid and potent convulsant in the
neonatal rat [10]. Seizures occur with a latency of as little as 2 minutes and with CRH doses
as low as 7.5 × 10−12 mo! or 0.05 × 10−9 mol/gm of brain weight [10]. The present study
was designed to define the neurobiological matrix of the behavioral and electrographic
effects of the neuropeptide. We used infant rats, starting on postnatal day 5.
Materials and Methods
Animals
Timed-pregnancy Sprague–Dawley–derived rats were obtained from Zivic-Miller
(Zelionplc, PA). They were housed under a 12-hour light/dark cycle and fed ad libitum.
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Delivery times were monitored and were accurate to within 12 hours. The day of birth was
considered day zero. The pups were kept with the mothers, and litters were culled to 12
pups. Infant rats were subjected to surgery 24 hours before recording and returned to their
mothers. CRH was always administered between 9 and 10:30 AM, to minimize diurnal
variations in seizure susceptibility [11] and in endogenous CRH levels [12].
Surgical Procedure
Electrodes were implanted under halothane anesthesia, using an infant rat stereotaxic
apparatus as previously described [10, 13]. Two or four cortical stainless-steel electrodes
were placed over the frontal and posteroparietal cortex. Bipolar twisted wire electrodes,
enameled except for the tip, were used. Electrodes were inserted through a burr hole into the
amygdala or hippocampus (wire diameter, 0.1–0.15 mm; vertical intertip distance, 0.5–1.0
mm). Electrodes were anchored to the skull with an acrylic cement “cap” attached also to
two screws. Age-specific basal-lateral amygdala coordinates, with reference to bregma, were
adapted for our strain [14] and are shown in Table 1.
In each age group, several rat pups carried bipolar hippocampal electrodes (Table 2). These
were aimed at the dorsal or ventral hippocampus, either simultaneously with those in the
amygdala or with a larger array of cortical electrodes. Age-specific coordinates for
hippocampal electrodes are shown in Table 2. CRH was injected via a cannula placed
stereotaxically in the lateral ventricle [10].
Electrophysiology and Behavior Monitoring
Recordings were performed in heated, shielded Plexiglas chambers. A Grass 78E Polygraph
(Grass Instrument Co, Quincy, MA) was connected via long, flexible wires to freely moving
rat pups, which were continuously observed throughout the recording. To ascertain the
cerebral origin of recorded discharges, two maneuvers were undertaken. At least 1 rat pup
per age was restrained (using medical tape) in an infant-rat stereotaxic apparatus. This
prevented all motion of electrodes and wires. Electrographic recordings were compared with
those of unrestrained peers, and with those obtained without restraint from the same pup. In
addition, a motion-detecting bipolar electrode (“EMG”), was attached to the angle of the jaw
or the chest and connected to the Polygraph.
After a 30-minute habituation and baseline recording period, CRH or saline was
administered intracerebroventricularly in 1 to 4 μl (depending on dose and animal age) using
a microinfusion pump. CRH doses used were 0.0375 to 0.3 nmol. These doses have been
found to elicit behavioral epileptic phenomena in infant rats [10]. Electrographic recording
and observation of behavior were supplemented by intermittent video recording. These
procedures were performed for a minimum of 4 hours, or for at least 1 hour subsequent to
cessation of abnormal activity. At the end of each experiment, electrolytic lesions were
created at the bipolar electrode tips. Rat pups were killed and brains frozen on dry ice.
Brains were cut into 20-μm sections and stained with cresyl violet for verification of
electrode placement.
Seizure definition has been discussed in detail elsewhere [10]. Briefly, behavioral
phenomena were considered epileptic if (1) they were not seen before CRH administration
[10], and (2) they were recognized as epileptic in infant [15–17] and adult rats [18–20].
Though no formal grading system was used, observed behaviors conformed to the infantile
scale of kindling-induced phenomena [15, 17]. The correlation of specific behaviors and
electrographic discharges, the goat of this study, is discussed in the following section.
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Results
The ages of rats, doses of CRH administered, and times to onset of CRH-induced seizure are
shown in Table 3. Age-specific electrographic and behavioral phenomena are summarized in
Table 4. The detailed sequence of age- and dose-dependent CRH-induced behavioral events
has been described elsewhere [10].
At the end of the first postnatal week, minimal effective CRH doses (0.038 nm or 38 pm)
resulted in stereotyped behaviors (see Table 4). These were accompanied, in most rat pups
carrying amygdala electrodes (5 of 6 pups), by abnormal discharges. Semirhythmic spike
waves (Fig 1B, D), the appearance of low-amplitude fast (13–15 Hz) activity in the
amygdala leads (Fig 1C), or both preceded the onset of jaw myoclonus in 3 of 6 rat pups. In
2 additional pups, amygdala discharges followed the onset of behavioral events. These
discharged were confined to the bipolar amygdala leads and to those connected co both
amygdala and homologous cortex.. No paroxysmal discharges were recorded from either
ventral or dorsal hippocampus (not shown).
CRH-induced amygdala discharges in 8- to 10-day-old infant rats are shown in Figure 2.
The baseline electroencephalogram (EEG) at this age was more developed than in younger
pups (see Fig 2A). Figure 2B, 9 minutes subsequent to administration of CRH, shows
rhythmic slow wave discharges in the amygdala leads, which did not correlate with chest
motion or with the rhythm of jaw myoclonus (“EMG”). The latency of paroxysmal
amygdala discharges and accompanying behaviors (see Table 4) was dose dependent. Using
015 nm of CRH, frequent electrographic and behavioral seizures persisted for 4 to 5 hours.
The first two panels of Figure 3 illustrate the electrographic correlates of CRH-induced
seizures in a pup carrying both amygdala and ventral hippocampus (VH) electrodes. By the
end of the second postnatal week (days 11–14), CRH induced repetitive, well-formed sharp
wave discharges confined to amygdala leads (Fig 4B–D). No paroxysmal discharges were
present in simultaneously recorded dorsal hippocampus and cortex. Rare sharp hippocampal
and cortical spikes (see Fig 4D) could not be distinguished with certainty from motion
artifacts. In a different rat pup, persistent jaw myoclonus was not associated with abnormal
discharges in VH leads (see Fig 3C, D).
During the third postnatal week, larger closes of CRH (0.15 nm or more) were needed to
elicit seizures. Behavior was limited to persistent, uncontrollable jaw myoclonus
accompanied by grooming, scratching, and so on. Loss of balance was observed in only one
16-day-old pup (given 0.3 nm of CRH), and clonus was not common. CRH (0.15–0.75 ×
10 −9 mol) induced spike wave discharges in amygdala leads (Fig 5B). Despite recording
periods of up to 9 hours, propagation to hippocampal or conical leads was only rarely
observed (not shown). Placement of electrodes in amygdala and dorsal and ventral
hippocampus is seen in Figure 6.
Discussion
CRH induces convulsions in adult rats [6–8, 21], though the time course and origin of
paroxysmal discharges remain unresolved, Ehlers [7] and Ehlers and colleagues [6]
demonstrated the onset of amygdala spikes 1 to 3 hours after the administration of CRH.
Behavioral seizures, most commonly jaw myoclonus, developed 3 to 7 hours later. These
were accompanied by the spread of paroxysmal discharges to the hippocampus and cortex
[6]. Other investigators [8, 21, 22] have described CRH-induced epileptiform discharges
localized to the hippocampal leads in both rats and rabbits. Minimal latency to hippocampal
spikes was 35 to 39 minutes [22].
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We have found CRH to be a more rapid and potent convulsant in the neonatal and infant rat
compared with the adult rat [10]. Jaw myoclonus developed in less than 2 minutes, and
effective peptide doses were as low as 0.0075 nmol (50 × 10−12 mol/gm of brain weight).
Reported convulsant doses of CRH in the adult were 1.5 to 3.75 nmol, or 750 × 10−12 mol/
gm of brain weight [6] The underlying mechanisms for this age-dependent potency and
rapidity of action of CRH remain unclear. CRH gene expression increases markedly at the
end of the first postnatal week [23, 24]. That, coupled with a maximal number of CRH
receptors present at that time [25], may partially explain this phenomenon.
The neuroanatomical substrate of CRH-induced seizures in the infant rat has not been
elucidated. Cortical electrographic correlates of behavioral phenomena have been
inconsistent [10], and data regarding adult rodents are in disagreement [6–8, 21, 22]. Jaw
myoclonus as an epileptic phenomenon has been extensively described in both adult [6, 20]
and infant rats [16, 26, 27]. Some authors ascribe the origin of jaw myoclonus exclusively to
the amygdaloid complex [19]. After kainic acid administration, jaw myoclonus has been
found as a manifestation of limbic seizures originating in the hippocampus and spreading to
the amygdala [16, 18, 20].
Electrographic recording from discrete structures in the neonatal and infant rat is fraught
with difficulties due to the small size of brain regions, the low voltage of EEG discharges,
and the presence of motion artifacts. Localization was achieved using bipolar amygdala
electrodes and validated in smaller animals via amygdala–cortex leads. Not uncommonly,
paroxysmal discharges were confined to bipolar amygdala and only one amygdala–cortex
lead. Simultaneous recording was obtained from amygdala and either dorsal or ventral
hippocampus. Paroxysmal discharges originated from the amygdala (see Figs 3, 4).
Movement artifacts were avoided by several maneuvers. EEGs of completely restrained rat
pups were compared with those of free-moving pups. Rat pups were observed constantly,
and a motion-detecting electrode was placed at the angle of the jaw or around the chest. The
latter detected the increased ventilatory rate and amplitude induced by CRH [28].
Curarization [29] was avoided because it has been reported to alter EEGs in adult rats [30].
The assignment of the amygdala as the origin of CRH-induced paroxysmal discharges is
compatible with the observed behavioral phenomena. Furthermore, the amygdala is quite
rich in CRH. The central amygdaloid nucleus has the highest concentration of the
neuropeptide in the brain [31, 32]. CRH receptors have been demonstrated in the central
amygdaloid nucleus and basolateral amygdala [33].
In conclusion, we have demonstrated that age-specific CRH-induced seizures originate in
the amygdala. The role of this neuropeptide as an endogenous convulsant in the immature
brain, as well as its potential role in the enhanced susceptibility of the neonatal brain to
epilepsy, remain speculative [10, 34].
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Fig 1.
Electroencephalograms of a 5-day-old rat. (A) Before corticotropin-releasing hormone
(CRH) infusion. (B, C, D, and E) Two, 11.5, 20, 59. and 85 minutes after infusion of 0.15
nmol of CRH into the cerebral ventricle. AMYC = amygdala; CORT = cortex; AMYG1/
AMYG2 =one of the wires of the bipolar amygdala electrode. R/L = right / left. Vertical bar
= 50 μV; horizontal bar = 1 second.
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Fig 2.
Electroencephalograms of a 9-day-old rat before corticotropin-releasing hormone (CRH)
administration (A), and 9 and 120 minutes after intracerebroventricular infusion of 015 nm
of CRH (B, C). The onset of semirhythmic slow wave discharges, confined to amygdala
leads (AMYG). is evident in B. They persisted intermittently for several hours (C). CORT =
cortical lead; EMG = motion-detecting electrodes placed over the angle of the jaw. Vertical
bar = 50 μV; horizontal bar = 1 second.
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Fig 3.
(A, B) Electroencephalograms (EEGs) of an 8-day-old infant rat. carrying both bipolar
amygdala (AMYG) and ventral hippocampus (VH) electrodes, before administration of
corticotropin-releasing hormone (CRH) (A) and 8 minutes after administration of 0.15 nm of
the peptide (B). Paroxysmal discharges originate in the amygdala leads. Movement artifacts
are later seen in all leads. (C, D) EEGs of an 11-day-old rat before (C). and 26 minutes
subsequent to the administration of 0.15 nm of CRH. Though the pup displayed jaw
myoclonus, only attenuation of the theta rhythm is seen in the ventral hippocampus (VH).
CORT = cortex; AMYG-CORT/VH-CORT = a lead combining one of the subcortical
electrodes to the cortical one. Vertical bar = 50 μV; horizontal bar = 1 second.
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Fig 4.
Electroencephalograms of a 13-day-old rat. (A) Baseline. (B. C. and D) Two. 35. and 174
minutes after intracerebro-ventricular administration of 0.15 nm of corticotropin-releasing
hormone. High-voltage, repetitive discharges are present exclusively in bipolar amygdala
(AMYG) and amygdala-cortex (A–C) leads, and not in bipolar hippocampal (DH). DH–
cortex (DH–C), or the motion-detecting (EMG) leads. Vertical bar = 50 μV; horizontal bar =
1 second.
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Fig 5.
Electroencephalograms (EEGs) of an 18-day-old rat. (A) Baseline. (B. C) Nine and 143
minutes after intracerebroventrkular administration of cortkotropin-releasing hormone (0.3
nm). High-voltage spike and slow wave discharges confined to the amygdala (latency. 4
minutes) (B). Two hours later, amygdala EEG has normalized (C). AMYG = amygdala;
CORT = cortex; A–C = amygdala–cortex lead; EMG = motion-detecting electrode (see
text). Vertical bar = 50 μV; horizontal bar = 1 second.
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Fig 6.
Histological verification of electrode placement in subcortical structures of the infant rat,
Cresyl blue–stained. 20-μm-thick coronal sections. (A) Amygdala (AMYG) and dorsal
hippocampus (DH) (B) Ventral hippocampus (VH).
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Table 1
Age-Specific Basal-Lateral Amygdala Coordinates
Age (days) AP Lat V
4–5 −1.5 3.5 6.0
7–9 −1.5 3.6 8.0
10–12 −1.5 3.6 8.0
15–17 −1.5 3.6 8.5
AP = anteroposterior; Lat = lateral; V = ventral.
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Table 4
Behavioral and EEG Characteristics of CRH-induced Seizures: Age Dependence
Age (days) Behavior Electrographic Correlates
5–6 JM; forepaw grooming and clonus; tonus; LOB Amygdala; semirhythmic spikes (4/6); fast activity (2/6)
8–10 JM; semirhythmic fore paw clonus (run); LOB Rhythmic slow wave or spike wave; rare cortical discharge
11–14 JM; grooming, scratching; “swimming”; LOB Amygdala rhythmic spike wave; rare H or cortex sharp waves
16–22 JM; grooming; rare LOB or “major” seizures Similar to 11- to 14-day-old group; higher voltage
EEG = electroencephalography, CRH = corticotropin-releasing hormone, JM = jaw myoclonus manifesting as vigorous, persistent, and unstoppable
licking and chewing; LOB = loss of balance; H = hippocampus.
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